Nektar Therapeutics
OLIGOMER-OPIOID AGONIST CONJUGATES
Last updated:
Abstract:
The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.
Status:
Application
Type:
Utility
Filling date:
24 Apr 2019
Issue date:
15 Aug 2019